Kirsten L. Greene, MD, MAS, FACS, discusses the future of personalized therapy in prostate cancer.
Kirsten L. Greene, MD, MAS, FACS
Advertisement
Articles by Kirsten L. Greene, MD, MAS, FACS
Advertisement
Latest Updated Articles
Dr. Greene on the Future of Personalized Therapy in Prostate CancerNovember 18th 2020
Advertisement
Advertisement
Trending on OncLive
1
FDA CTGTAC Votes in Favor of RP1/Nivolumab Data in Advanced Melanoma
2
Dr Barot on the FDA Approval of Palbociclib/Trastuzumab ± Pertuzumab in HER2+ Breast Cancer
3
Dr Galsky on Data Supporting the FDA Approval of Perioperative EV/Pembrolizumab in MIBC
4
European Commission Approves First-Line Dato-DXd for Immunotherapy-Ineligible Metastatic TNBC
5